|
|
||||||||
The FASEB Journal, Vol 2, 2497-2504, Copyright © 1988 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
MB Vivaudou, LH Clapp, JV Walsh Jr and JJ Singer
Department of Physiology, University of Massachusetts Medical School, Worcester 01655.
Electrophysiological recordings from freshly dissociated smooth muscle cells from the stomach of the toad Bufo marinus revealed two types of Ca2+ currents. One has a low threshold of activation and inactivates rapidly; the other has a high threshold of activation and inactivates more slowly. Acetylcholine (ACh) increased the high-threshold current but not the low-threshold current. The synthetic diacylglycerol analog sn-1,2-dioctanoylglycerol, an activator of protein kinase C (PKC), mimicked these effects of ACh on Ca2+ currents. However, another diacylglycerol analog, 1,2-dioctanoyl-3-thioglycerol, which has a closely related structure but does not activate PKC, failed to increase the Ca2+ current. The same was true of 1,2-dioctanoyl-3- chloropropanediol, an analog that even at high concentrations only minimally activates PKC. These results suggest that diacylglycerol may be the second messenger mediating the effects of ACh on one type of voltage-activated Ca2+ channel, possibly by activating PKC.
This article has been cited by other articles:
![]() |
S. Bova, L. Trevisi, L. Cima, S. Luciani, V. Golovina, and G. Cargnelli Signaling Mechanisms for the Selective Vasoconstrictor Effect of Norbormide on the Rat Small Arteries J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 458 - 463. [Abstract] [Full Text] |
||||
![]() |
M. J. Davis and M. A. Hill Signaling Mechanisms Underlying the Vascular Myogenic Response Physiol Rev, April 1, 1999; 79(2): 387 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. KURIYAMA, K. KITAMURA, T. ITOH, and R. INOUE Physiological Features of Visceral Smooth Muscle Cells, With Special Reference to Receptors and Ion Channels Physiol Rev, July 1, 1998; 78(3): 811 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Frishman Mibefradil: A New Selective T-Channel Calcium Antagonist for Hypertension and Angina Pectoris Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 321 - 330. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |